HM

Hemant Modi

Director Director DIN 03621509
DIN 03621509 First appointment Aug 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2011
Shareholding value •••• Premium profile

About Hemant Modi

Data last updated:

Hemant Modi was a Director at Nestor Pharmaceuticals Limited (2011–2013) and Designated Partner at Cloud 9 Fincap Advisors Llp (2012–2017). The companies operate in Pharma and Business Services.

DIN 03621509
Primary Designation Director
Industry Pharma
First Appointment 01 Aug 2011

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nestor Pharmaceuticals Limited U24231DL1975PLC007959
Director01 Aug 20111975₹222 Cr (FY 2025)Active
Designated Partner09 Jul 20122012Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nestor Pharmaceuticals Limited
Cloud 9 Fincap Advisors Llp
Premium access

Shareholding and investment profile for Hemant Modi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemant Modi

Hemant Modi was first appointed on 01 Aug 2011 as Director at Nestor Pharmaceuticals Limited. The most recent appointment on record is 09 Jul 2012 at Cloud 9 Fincap Advisors Llp.

Hemant Modi held 2 earlier board appointments: Nestor Pharmaceuticals Limited (Director, 01 Aug 2011 to 07 Oct 2013); Cloud 9 Fincap Advisors Llp (Designated Partner, 09 Jul 2012 to 25 Jan 2017).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available